Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Riedmann

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Human Vaccines & Immunotherapeutics|November 15, 2014
Evolution of whooping cough bacterium may reduce vaccine effectivenessEva M Riedmann
Human Vaccines & Immunotherapeutics|March 2, 2013
GSK's four-strain seasonal influenza vaccine approved in the USEva M Riedmann
Human Vaccines & Immunotherapeutics|August 28, 2013
CDX-1401 combined with TLR agonist: positive phase 1 resultsEva M Riedmann
Human Vaccines & Immunotherapeutics|August 28, 2013
Visionary concept: printable vaccinesEva M Riedmann
Human Vaccines & Immunotherapeutics|April 10, 2014
Chinese scientists develop bird flu vaccineEva M Riedmann
Human Vaccines & Immunotherapeutics|April 10, 2014
Two-dose vaccination program shows positive impact on varicella incidenceEva M Riedmann
Human Vaccines & Immunotherapeutics|June 26, 2014
Pneumococcal vaccination does not prevent myocardial infarctionEva M Riedmann
Human Vaccines & Immunotherapeutics|January 13, 2015
Agenus‘ genital herpes vaccine significantly reduces viral burden in Phase 2Eva M Riedmann
Human Vaccines & Immunotherapeutics|January 13, 2015
ACIP ponders recommendation for Prevnar use in seniorsEva M Riedmann
Human Vaccines & Immunotherapeutics|August 28, 2013
Therapeutic vaccine for treatment of genital herpes enters phase 2Eva M Riedmann
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Human Vaccines & Immunotherapeutics|November 15, 2014
Evolution of whooping cough bacterium may reduce vaccine effectivenessEva M Riedmann
Human Vaccines & Immunotherapeutics|March 2, 2013
GSK's four-strain seasonal influenza vaccine approved in the USEva M Riedmann
Human Vaccines & Immunotherapeutics|August 28, 2013
CDX-1401 combined with TLR agonist: positive phase 1 resultsEva M Riedmann
Human Vaccines & Immunotherapeutics|August 28, 2013
Visionary concept: printable vaccinesEva M Riedmann
Human Vaccines & Immunotherapeutics|April 10, 2014
Chinese scientists develop bird flu vaccineEva M Riedmann
Human Vaccines & Immunotherapeutics|April 10, 2014
Two-dose vaccination program shows positive impact on varicella incidenceEva M Riedmann
Human Vaccines & Immunotherapeutics|June 26, 2014
Pneumococcal vaccination does not prevent myocardial infarctionEva M Riedmann
Human Vaccines & Immunotherapeutics|January 13, 2015
Agenus‘ genital herpes vaccine significantly reduces viral burden in Phase 2Eva M Riedmann
Human Vaccines & Immunotherapeutics|January 13, 2015
ACIP ponders recommendation for Prevnar use in seniorsEva M Riedmann
Human Vaccines & Immunotherapeutics|August 28, 2013
Therapeutic vaccine for treatment of genital herpes enters phase 2Eva M Riedmann
Pageof 10